Supreme Court Protects Access to Mifepristone, But War on Abortion Rights Continues to Escalate
The Supreme Court has unanimously rejected a challenge from anti-abortion groups to the nationwide availability of the abortion medication mifepristone, which is available by mail and can be taken at home in many states. However, advocates warn the far-right-dominated court’s ruling on the FDA’s authority to regulate the pill was purely on procedural grounds, and could even offer a “roadmap” for future challenges. Mifepristone is used in roughly two-thirds of all U.S.